AMBQ

Ambiq is a real ultra-low-power edge-AI semiconductor franchise with a genuinely improving cost structure: FY2025 gross profit rose +32.1% to $32.1M even as revenue fell, lifting gross margin to 44.3%, and the net loss narrowed +8.1% to -$36.5M. The balance sheet is the standout — the July 2025 NYSE IPO left $140M of cash (up 130%), equity of $162M against just $22.2M of liabilities (0.14x), and current assets of $168M vs. $19.2M current liabilities. With operating cash burn of only -$19.7M, the company has multiple years of runway and no solvency risk. This is not a quality-disaster 'avoid.'

The problem is the price, not the company. At $85.05 the market cap is $1.81B — roughly 24.9x FY2025 revenue — yet that revenue is DECLINING: $72.5M in FY2025 vs. $76.1M in FY2024, a -4.7% drop. A ~25x sales multiple is the kind of figure paid for hyper-growth; here it is being paid for contraction. The operating model is still deeply red (operating income -$39.5M, -54.5% operating margin; net margin -50.3%; ROE -22.4%) with R&D of $38.5M consuming more than half of all revenue and a -$357M accumulated deficit. The improving gross margin and narrowing loss are encouraging, but they are improvements on a shrinking base — the valuation is discounting a re-acceleration the filings describe only as aspiration (design wins, AI integration) rather than as realized results.